AI assistant
Tectonic Therapeutic, Inc. — Director's Dealing 2019
Jan 4, 2019
33251_dirs_2019-01-04_ceca5cbd-d98b-4f0c-9e12-26aa3633cd82.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2019-01-02
Reporting Person: Ostrowski Erik (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-02 | Common Stock | A | 2300 | $0.00 | Acquired | 2300 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-01-02 | Stock Option (Right to Buy) | $15.65 | A | 186000 | Acquired | 2029-01-01 | Common Stock (186000) | Direct |
Footnotes
F1: The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent
right to receive one share of AVROBIO, Inc., common stock. The restricted stock units vest as follows: 25% of the shares vest on January 2, 2020, and the
remaining 75% shall vest in equal monthly installments thereafter over a three-year period.
F2: 25% of the shares vest on January 2, 2020, and the remaining 75% shall vest in equal monthly installments thereafter over a three-year period.